Aashish Manglik

Aashish Manglik is a prominent physician-scientist and co-founder of Stipple Bio. He currently serves as an Associate Professor at the University of California, San Francisco (UCSF).1

Professional Background

Dr. Manglik's career in academia has been impressive:

• He joined UCSF as an Assistant Professor in September 2017 and was promoted to Associate Professor in July 2021.1
• Prior to UCSF, he was a Stanford Distinguished Fellow at Stanford University School of Medicine from June 2016 to August 2017.1
• He completed his MD and PhD in Biophysics at Stanford University between 2008 and 2016.1

Research Focus

Dr. Manglik's research interests lie in understanding human physiology from a biochemical perspective. He is particularly focused on:

• G protein-coupled receptors (GPCRs), the largest group of drug targets in the human body.2
• Developing new medications that are more effective and have fewer side effects.2
• Studying how cells sense and respond to their external environment.2

Entrepreneurial Ventures

In addition to his academic work, Dr. Manglik has ventured into entrepreneurship:

• He co-founded Stipple Bio in May 2022 and continues to be involved with the company.1
• He is also a founder of Epiodyne and serves as a consultant for Abalone.3
• Dr. Manglik is on the scientific advisory board of Septerna.3

Achievements and Recognition

Throughout his career, Dr. Manglik has received several honors:

• He was named a Bowes Biomedical Investigator at UCSF in 2024.2
• He received the Byers Award Lecture in Basic Science at UCSF in 2024.2
• In 2022, he was awarded the Young Investigator Award by Amgen.2
• He was recognized in Scientific American's "30 under 30" list in 2013.2

Dr. Manglik's work bridges the gap between basic scientific research and practical applications in medicine, making him a notable figure in both academic and biotechnology circles.